TORONTO, ONTARIO--(Marketwired - June 22, 2015) - Biosenta Inc. (Biosenta) (CSE:ZRO) is pleased to announce that its disinfectant, called "True," has been approved by the Environmental Protection Agency (EPA) in the U.S.A. Further, the EPA has allowed True to not carry a warning, caution or danger label because it is very safe for human use.
True is a new disinfectant and cleaner which effectively kills a multitude of potentially deadly microbes (bacteria, viruses and fungi/mould) with a formulation that has been shown to be very safe for use. The innovation which gives True its unique properties is that it is both a very powerful disinfectant and it contains very low levels of active ingredients which make it much less toxic and more safe.
Mr. Dene Rogers, President and CEO of Biosenta, said, "True is a unique disinfectant that matches the best products on the market and it has the advantage of having a formulation that is very safe for use. Gaining EPA approval will allow Biosenta to begin to launch sales in the U.S., a market which is almost ten times the size of Canada."
Laboratory testing of True on a broad range of potentially deadly microbes has been conducted by a world-renowned institution. These standardised tests have shown True will kill 100% of the following microbes within a 10 minute contact time:
Bacteria | Virus | Fungi | ||
Acinetobacter Baumannii (ABC) | Adenovirus | Black mould | ||
E. coli | Chlamydia | Trichophyton mentagrophytes | ||
Listeria | Ebola | |||
MRSA | Enterovirus D68 | |||
Pseudomonas aeruginosa | H1N1 | |||
Salmonella | Hepatitis | |||
Staphylococcus aureus | Herpes | |||
HIV | ||||
Influenza | ||||
Polio | ||||
Respiratory Syncytial Virus | ||||
Rotavirus | ||||
Swine Flu | ||||
Tuberculosis | ||||
Vaccina (pox virus) |
Note that the Ebola and Enterovirus D68 claims are based on scientific rationale as provided by the U.S. Center for Disease Control. Please refer to Biosenta.com for details of the laboratory testing.
Approval to market and sell True in Canada is underway. The approval process in Canada was commenced in December, 2014 and approvals from Health Canada are expected in late-2015.
About Biosenta Inc.
Biosenta Inc. develops and manufactures a range of chemical compounds for household and industrial applications using advanced nanotechnology.
Biosenta household disinfectants and cleaners possess similar levels of efficacy as traditional disinfectants but with significantly lower concentrations of active ingredients resulting in lower toxicity. These disinfectants and cleaners will kill 100% of potentially deadly mould, fungi, bacteria and viruses on contact and prevent re-growth. The disinfectants are very safe due to very low toxicity.
The industrial compounds are embedded to protect various materials, including drywall, plastics and resins, from microbe formation. These compounds remain active for decades and protect the drywalls of buildings, objects such as furniture, and carpet which contain plastic or resin, as well as textiles and paper from mould, fungi, bacteria and viruses.
Both the household and industrial products are environmentally safe and biodegradable.
Disclaimer
The CSE has in no way passed upon the contents of the information in this press release and has neither approved nor disapproved of the contents of this press release. Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this press release.
This press release is provided in good faith by the Company and every effort has been made to ensure the information is accurate and complete. However, the Company does not represent or guarantee the complete accuracy of the information contained within this document, especially as new information becomes available after the publication of this press release. Further, the Company advises any reader of this press release to not use this document or the information contained therein for the purposes of making investment decisions in the Company without using other public information, such as the Company's financial reports and press releases, consulting with qualified advisors, and any other reliable source of information.
This press release may contain forward-looking statements information and statements which constitute "forward-looking information" under Canadian securities law and which may be material regarding, among other things, the Company's beliefs, plans, objectives, estimates, intentions and expectations with respect to its operations, capital and funding plans. Inherent in the forward-looking information and statements are known and unknown risks, uncertainties and other factors beyond the Company's ability to control or predict, which give rise to the possibility that the Company's predictions, forecasts, expectations or conclusions will not prove to be accurate, that its assumptions may not be correct and that the Company's plans, objectives and statements will not be achieved. Actual results or developments may differ materially from those contemplated by the forward-looking information and statements. Consequently, undue reliance should not be placed on such forward-looking statements. The forward-looking information and statements contained in this document about prospective results of operations, financial position, business development and operations are based on current assumptions of the Company. Forward-looking information and statements reflect the Company's views only as of the date of this press release.
Contact Information:
Dene Rogers
President and CEO
416-410-2019
dene@biosenta.com